 |
|
 |
UM Guidelines |
|
|
|
||||||
| |
||||||
| Allogeneic Bone Marrow and Peripheral Blood Stem Cell Transplants |
Ambulatory Care (AC): A-0376 |
| Effective November 16, 2011* |
Added to: Clinical Indications
- Allogeneic bone marrow or peripheral blood stem cell transplants may be indicated for...
- ...
- Myeloproliferative neoplasms
References
- A Cancer Journal for Clinicians. (2011, June). Advances in understanding and management of myeloproliferative neoplasms. Retrieved June 28, 2001 from http://caonline.amcancersoc.org/cgi/content/full/59/3/171.
- BlueCross BlueShield Association. Medical Policy Reference Manual. (11:2010). Allogeneic stem-cell transplantation for myelodysplastic syndromes and myeloproliferative neoplasms (8.01.21). Retrieved June 7, 2011 from BlueWeb.
- BlueCross BlueShield of Tennessee network physicians. June – September 2011.
- Complete Guide to Medicare Coverage Issues [Computer software]. (2011, April). Stem Cell Transplantation (NCD 110.8.1, p. 2-56). Ingenix.
